Olverembatinib dimesylate
Product Specifications
CAS Number
1421783-64-3
Target
Bcr-Abl
Related Pathways
Cytoskeletal Signaling, Tyrosine Kinase/Adaptors, Angiogenesis
Purity
>99.99%
Bioactivity
Olverembatinib dimesylate (GZD824 Dimesylate) is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl (WT) and Bcr-Abl (T315I) .
Smiles
CS(O)(=O)=O.CS(O)(=O)=O.CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4[nH]ncc4c3)cc2C(F)(F)F)CC1
Molecular Formula
C29H27F3N6O·2CH4O3S
Molecular Weight
724.77
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY418750 100 µg
DAP12 (TYROBP) (NM_003332) Human Over-expression Lysate
Sign In for Pricing
View Details 